Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03539705
Other study ID # 36273
Secondary ID 1UM1AI130839-01
Status Recruiting
Phase
First received
Last updated
Start date January 5, 2018
Est. completion date May 2028

Study information

Verified date November 2023
Source Stanford University
Contact SNP Center Inquiry
Phone 650-521-7237
Email snpcenterallergy_inquiry@stanford.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a registry of participants who are interested in being screened for clinical trials at a single site.


Description:

This registry will be maintained on a secure database and will include name, gender, age, disease, medical information, other information (via questionnaires), and date of consent. It will be overseen by our regulatory manager at our site and will not be shared with others outside of our site-specific trained individuals.


Recruitment information / eligibility

Status Recruiting
Enrollment 6000
Est. completion date May 2028
Est. primary completion date May 2028
Accepts healthy volunteers
Gender All
Age group 0 Years to 100 Years
Eligibility Inclusion Criteria: - Any interested party from 0-100 yrs of age to enter their information in registry Exclusion Criteria: - Any individual who does not consent

Study Design


Intervention

Other:
There is no intervention
There is no intervention

Locations

Country Name City State
United States Stanford University Palo Alto California

Sponsors (3)

Lead Sponsor Collaborator
Stanford University Food Allergy Research & Education, National Institute of Allergy and Infectious Diseases (NIAID)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Registry to provide a list of interested individuals in clinical trials at a single site The clinical trials could be either allergy or asthma studies 4 years
See also
  Status Clinical Trial Phase
Completed NCT01205659 - Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula N/A